Personensuche
Personensuche
Es wurde 1 Person gefunden.
E-Mail
Funktionen
-
apl. Professor/in und Privatdozent/in, Klinik für Endokrinologie
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Diagnosis and management of hypertension in patients with Cushing's syndrome : a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionIn: Journal of Hypertension Jg. 40 (2022) Nr. 11, S. 2085 - 2101ISSN: 1473-5598; 0263-6352Online Volltext: dx.doi.org/
-
Consensus on diagnosis and management of Cushing's disease : A guideline updateIn: The Lancet Diabetes & Endocrinology Jg. 9 (2021) Nr. 12, S. 847 - 875ISSN: 2213-8595; 2213-8587Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and SwitzerlandIn: Experimental and Clinical Endocrinology & Diabetes Jg. 129 (2021) Nr. 3, S. 224 - 233ISSN: 1439-3646; 0947-7349Online Volltext: dx.doi.org/
-
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and AustriaIn: Experimental and Clinical Endocrinology & Diabetes Jg. 129 (2021) Nr. 07, S. 500 - 509ISSN: 0232-7384; 1439-3646Online Volltext: dx.doi.org/ (Open Access)
-
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas -A German SurveyIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 105 (2020) Nr. 3, S. e660 - e675ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/ (Open Access)
-
Pituitary Disease in Pregnancy : Special Aspects of Diagnosis and Treatment?In: Geburtshilfe und Frauenheilkunde Jg. 79 (2019) Nr. 4, S. 365 - 374ISSN: 1438-8804; 0016-5751Online Volltext: dx.doi.org/ (Open Access)
-
Aggressive pituitary tumours and carcinomas : two sides of the same coin?In: European Journal of Endocrinology Jg. 178 (2018) Nr. 6, S. C7 - C9ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/ (Open Access)
-
Black swans - neuroendocrine tumors of rare locationsIn: Reviews in Endocrine and Metabolic Disorders Jg. 19 (2018) Nr. 2, S. 111 - 121ISSN: 1389-9155Online Volltext: dx.doi.org/
-
Efficacy and safety of once-monthly pasireotide in Cushing's disease : a 12 month clinical trialIn: The Lancet Diabetes & Endocrinology Jg. 6 (2018) Nr. 1, S. 17 - 26ISSN: 2213-8587Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomasIn: European Journal of Endocrinology Jg. 178 (2018) Nr. 1, S. G1 - G24ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/ (Open Access)
-
MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma : PRIMARYS post-hoc analysisIn: European Journal of Endocrinology Jg. 180 (2018) Nr. 3, S. 155 - 164ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/ (Open Access)
-
Neuroendocrine neoplasms - think about it and choose the most appropriate diagnostic and therapeutic stepsIn: Reviews in Endocrine & Metabolic Disorders Jg. 19 (2018) Nr. 2, S. 107 - 109ISSN: 1573-2606; 1389-9155Online Volltext: dx.doi.org/ (Open Access)
-
Pituitary disease management during pregnancy : an overviewIn: Minerva Endocrinologica Jg. 43 (2018) Nr. 4, S. 420 - 422ISSN: 0391-1977; 1827-1634Online Volltext: dx.doi.org/
-
Secondary adrenal insufficiency in pregnancy : any differences?In: Minerva Endocrinologica Jg. 43 (2018) Nr. 4, S. 446 - 450ISSN: 0391-1977; 1827-1634Online Volltext: dx.doi.org/
-
Treatment of aggressive pituitary tumours and carcinomas : results of a European Society of Endocrinology (ESE) survey 2016In: European Journal of Endocrinology Jg. 178 (2018) Nr. 3, S. 265 - 276ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/ (Open Access)
-
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionIn: JAMA Oncology Jg. 3 (2017) Nr. 9, S. 1204 - 1212ISSN: 2374-2445; 2374-2437Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Diagnostik und Therapie der Akromegalie : Notwendigkeit der gezielten Überwachung von KomorbiditätenIn: Der Internist Jg. 58 (2017) Nr. 11, S. 1171 - 1182ISSN: 1432-1289; 0020-9554Online Volltext: dx.doi.org/
-
Erratum : Histological criteria for atypical pituitary adenomas--data from the German pituitary adenoma registry suggests modificationsIn: Acta Neuropathologica Communications Jg. 4 (2016) S. 21ISSN: 2051-5960Online Volltext: dx.doi.org/
-
Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas : analysis of the German ACC registryIn: European Journal of Endocrinology Jg. 172 (2015) Nr. 4, S. 415 - 422ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/
-
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modificationsIn: Acta Neuropathologica Communications Jg. 3 (2015) S. 50ISSN: 2051-5960Online Volltext: dx.doi.org/ (Open Access)
-
How to manage pasireotide, when using as medical treatment for Cushing's diseaseIn: Endocrine Jg. 50 (2015) Nr. 3, S. 526 - 528ISSN: 1559-0100; 1355-008X; 0969-711XOnline Volltext: dx.doi.org/
-
Pituitary-directed medical therapy in Cushing's diseaseIn: Pituitary Jg. 18 (2015) Nr. 2, S. 238 - 244ISSN: 1573-7403; 1386-341XOnline Volltext: dx.doi.org/
-
Qualitätssicherung der Analytik von Wachstumshormon und Insulin-Like Growth Factor I bei Erkrankungen der somatotropen AchseIn: Laboratoriumsmedizin Jg. 39 (2015) Nr. 2, S. 81 - 86ISSN: 0342-3026; 1439-0477Online Volltext: dx.doi.org/
-
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer : Results from the European EURAF CohortIn: Annals of Oncology Jg. 26 (2015) Nr. S 1: European Lung Cancer Conference (ELCC), Geneva, Switzerland, 15-18 April 2015 : Abstracts, S. i61ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/
-
Total testosterone and calculated estimates for free and bioavailable testosterone : Influence of age and body mass index and establishment of sex-specific reference rangesIn: Hormone and metabolic research Jg. 47 (2015) Nr. 11, S. 846 - 854ISSN: 0018-5043Online Volltext: dx.doi.org/
-
Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine : own experience and overview of the contemporary literatureIn: Clinical Endocrinology Jg. 82 (2015) Nr. 1, S. 84 - 90ISSN: 0300-0664Online Volltext: dx.doi.org/
-
Erratum to : Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension studyIn: Pituitary Jg. 17 (2014) Nr. 2, S. 141ISSN: 1573-7403; 1386-341XOnline Volltext: dx.doi.org/
-
Expression Analysis of GADD45γ, MEG3, and p8 in Pituitary AdenomasIn: Hormone and metabolic research Jg. 46 (2014) Nr. 9, S. 644 - 650ISSN: 0018-5043Online Volltext: dx.doi.org/
-
High variability in baseline urinary free cortisol values in patients with Cushing's diseaseIn: Clinical Endocrinology Jg. 80 (2014) Nr. 2, S. 261 - 269ISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/ (Open Access)
-
Long-term efficacy and safety of subcutaneous pasireotide in acromegaly : results from an open-ended, multicenter, Phase II extension studyIn: Pituitary Jg. 17 (2014) Nr. 2, S. 132 - 140ISSN: 1573-7403; 1386-341XOnline Volltext: dx.doi.org/ (Open Access)
-
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease : results from a Phase III studyIn: Clinical Endocrinology Jg. 81 (2014) Nr. 3, S. 408 - 417ISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/
-
Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly : a randomized, multicenter, open-label, phase I studyIn: The Journal of Clinical Pharmacology Jg. 54 (2014) Nr. 11, S. 1308 - 1317ISSN: 0091-2700Online Volltext: dx.doi.org/
-
Sagit© : A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical PracticeIn: Value Health Jg. 17 (2014) Nr. 7, S. A355ISSN: 1098-3015; 1524-4733Online Volltext: dx.doi.org/
-
Somatuline Autogel treatment in Acromegaly-1 year data from SOPRANo studyIn: Experimental and Clinical Endocrinology & Diabetes Jg. 122 (2014) Nr. 3, S. P125ISSN: 0947-7349Online Volltext: dx.doi.org/
-
Spontaneous course of hypophysitis - data from a survey of the German Pituitary Working GroupIn: Experimental and Clinical Endocrinology & Diabetes Jg. 122 (2014) Nr. 3, OP7_33ISSN: 0947-7349Online Volltext: dx.doi.org/
-
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly : results of a prospective multicenter clinical trialIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 99 (2014) Nr. 4, S. 1282 - 1290ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Cardiac risk in patients with treatment naïve, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general populationIn: Experimental and Clinical Endocrinology & Diabetes Jg. 121 (2013) Nr. 2, S. 125 - 132ISSN: 0947-7349; 1439-3646; 0232-7384Online Volltext: dx.doi.org/
-
Cardiovascular risk in patients with hypopituitarism after surgery: comparison to matched data from the general populationIn: Experimental and Clinical Endocrinology & Diabetes Jg. 121 (2013) S. P65ISSN: 0947-7349; 0947-7349Online Volltext: dx.doi.org/
-
New avenues in the medical treatment of Cushing's disease : corticotroph tumor targeted therapyIn: Journal of Neuro-Oncology Jg. 114 (2013) Nr. 1, S. 1 - 11ISSN: 1573-7373; 0167-594XOnline Volltext: dx.doi.org/ (Open Access)
-
Preliminary Testing of the Sagit Tool : A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical PracticeIn: Value Health Jg. 16 (2013) Nr. 7, S. A447ISSN: 1098-3015; 1524-4733Online Volltext: dx.doi.org/ (Open Access)
-
Screening for Cushing's Syndrome : New Immunoassays Require Adequate Normative DataIn: Hormone and Metabolic Research Jg. 45 (2013) Nr. 2, S. 118 - 123ISSN: 0018-5043Online Volltext: dx.doi.org/
-
Treatment with temozolomide in aggressive pituitary tumors - data from a survey by the German Pituitary Study GroupIn: Experimental and Clinical Endocrinology & Diabetes Jg. 121 (2013) Nr. 3, OP1_02ISSN: 0947-7349Online Volltext: dx.doi.org/
-
A 12-Month Phase 3 Study of Pasireotide in Cushing's DiseaseIn: The New England Journal of Medicine Jg. 366 (2012) Nr. 10, S. 914 - 924ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/
-
Automated 22-kD Growth Hormone–Specific Assay without Interference from PegvisomantIn: Clinical Chemistry Jg. 58 (2012) Nr. 10, S. 1446 - 1456ISSN: 0009-9147; 1530-8561Online Volltext: dx.doi.org/
-
Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissuesIn: Experimental and Clinical Endocrinology & Diabetes Jg. 120 (2012) Nr. 8, S. 482 - 489ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
Effects of standard glucocorticoid replacement therapies on subjective well-being : A randomized, double-blind, crossover study in patients with secondary adrenal insufficiencyIn: European Journal of Endocrinology Jg. 167 (2012) Nr. 5, S. 679 - 685ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/
-
Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomasIn: Clinical Endocrinology Jg. 77 (2012) Nr. 1, S. 139 - 145ISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/
-
Medical management of Cushing's disease : what is the future?In: Pituitary Jg. 15 (2012) Nr. 3, S. 330 - 341ISSN: 1573-7403; 1386-341XOnline Volltext: dx.doi.org/
-
Pasireotide (SOM230), a Novel Multireceptor‐Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7‐Day Subcutaneous Infusion in Healthy Male VolunteersIn: Journal of Clinical Pharmacology Jg. 52 (2012) Nr. 7, S. 1017 - 1027ISSN: 0021-9754; 1552-4604; 0091-2700Online Volltext: dx.doi.org/
-
Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal massIn: Experimental and Clinical Endocrinology & Diabetes Jg. 120 (2012) Nr. 8, S. 494 - 500ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency : Improved screening by an automatic immunoassayIn: European Journal of Endocrinology Jg. 166 (2012) Nr. 4, S. 613 - 618ISSN: 1479-683X; 0804-4643Online Volltext: dx.doi.org/ (Open Access)
-
Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers : A Single-Center, Open-Label, Ascending-Dose StudyIn: Clinical Therapeutics Jg. 34 (2012) Nr. 3, S. 677 - 688ISSN: 0149-2918; 1879-114XOnline Volltext: dx.doi.org/
-
68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine TumorsIn: Journal of Nuclear Medicine Jg. 52 (2011) Nr. 12, S. 1864 - 1870ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/
-
68Ga-DOTATOC vs. 68Ga-DOTATATE PET/CT in functional imaging of Neuroendocrine TumoursIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 38 (2011) Nr. Suppl. 2, S. 97 - S98ISSN: 1619-7070; 1619-7089
-
Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center ExperienceIn: Hormone and Metabolic Research Jg. 43 (2011) Nr. 12, S. 838 - 843ISSN: 1439-4286Online Volltext: dx.doi.org/
-
Efficacy and Acceptability of Lanreotide Autogel® 120 mg at Different Dose Intervals in Patients with Acromegaly Previously Treated with Octreotide LARIn: Experimental and Clinical Endocrinology & Diabetes Jg. 119 (2011) Nr. 3, S. 156 - 162ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
Measurement of Urinary Free Cortisol by Current Immunoassays : Need for Sex-dependent Reference Ranges to Define HypercortisolismIn: Hormone and Metabolic Research Jg. 43 (2011) Nr. 10, S. 714 - 719ISSN: 1439-4286; 0018-5043Online Volltext: dx.doi.org/
-
Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia : Utility of salivary 17α- hydroxyprogesterone day profilesIn: Experimental and Clinical Endocrinology & Diabetes Jg. 119 (2011) Nr. 3, S. 131 - 138ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine : a Single-Center ExperienceIn: Experimental and Clinical Endocrinology & Diabetes Jg. 119 (2011) Nr. 9, S. 540 - 543ISSN: 0947-7349; 1439-3646Online Volltext: dx.doi.org/
-
⁶⁸Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUV mₐₓIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 38 (2011) Nr. 7, S. 1224 - 1236ISSN: 1619-7089; 1619-7089; 1432-105X; 0340-6997Online Volltext: dx.doi.org/
-
Association of somatostatin receptor 2 immunohistochemical expression with [¹¹¹In]-DTPA octreotide scintigraphy and [⁶⁸Ga]-DOTATOC PET/CT in neuroendocrine tumorsIn: Hormone and Metabolic Research Jg. 42 (2010) Nr. 8, S. 599 - 606ISSN: 0018-5043; 1439-4286Online Volltext: dx.doi.org/
-
Baseline Characteristics and Urine Free Cortisol (UFC) Variability of 162 Patients Enrolled in a Randomized, Double-Blind Phase III Study Assessing the Efficacy and Safety of Pasireotide (SOM230) in Patients with Cushings Disease
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine reviews: issued quarterly for the Endocrine Society Jg. 31 (2010) Nr. Suppl. 1,ISSN: 0163-769X; 1945-7189Online Volltext: dx.doi.org/ -
Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly : Comparison with matched data from the general population and the effect of disease controlIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 95 (2010) Nr. 8, S. 3648 - 3656ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/
-
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epitheliumIn: Hormone and Metabolic Research Jg. 42 (2010) Nr. 1, S. 61 - 64ISSN: 0018-5043; 1439-4286Online Volltext: dx.doi.org/
-
Diagnosis of adrenal insufficiency using the GHRP-6 test : Comparison with the insulin tolerance test in patients with hypothalamic-pituitary-adrenal diseaseIn: Hormone and Metabolic Research Jg. 42 (2010) Nr. 3, S. 198 - 203ISSN: 1439-4286; 0018-5043Online Volltext: dx.doi.org/
-
Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgeryIn: European Journal of Endocrinology Jg. 162 (2010) Nr. 3, S. 477 - 482ISSN: 1479-683X; 0804-4643Online Volltext: dx.doi.org/
-
Gibt es Hinweise auf ein Cushing-Syndrom? : Arterielle Hypertonie und AdipositasIn: MMW - Fortschritte der Medizin Jg. 152 (2010) Nr. 7, S. 39 - 41ISSN: 1613-3560; 1438-3276; 0341-3098Online Volltext: dx.doi.org/
-
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centersIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 95 (2010) Nr. 11, S. 4925 - 4932ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/
-
Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasmaIn: Clinical Endocrinology Jg. 73 (2010) Nr. 2, S. 153 - 160ISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/
-
Long-Term Treatment of Acromegaly with Pasireotide (SOM230) : Results from a Phase II Extension Study
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine reviews: issued quarterly for the Endocrine Society Jg. 31 (2010) Nr. Suppl. 1, OR 16-5ISSN: 0163-769X; 1945-7189Online Volltext: dx.doi.org/ -
Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly : A randomized, multicenter, phase II trialIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 95 (2010) Nr. 6, S. 2781 - 2789ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/ (Open Access)
-
Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s SyndromeIn: World Journal of Surgery Jg. 34 (2010) Nr. 6, S. 1391 - 1397ISSN: 0364-2313; 1432-2323Online Volltext: dx.doi.org/
-
Prolactinomas, Cushing's disease and acromegaly : Debating the role of medical therapy for secretory pituitary adenomasIn: BMC Endocrine Disorders Jg. 10 (2010) S. 10ISSN: 1472-6823Online Volltext: dx.doi.org/ (Open Access)
-
Randomized, Double-Blinded, Cross-Over Study Comparing Various Glucocorticoid Substitution Schemes in Secondary Adrenal Insufficiency
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine reviews: issued quarterly for the Endocrine Society Jg. 31 (2010) Nr. Suppl. 1,ISSN: 0163-769X; 1945-7189Online Volltext: dx.doi.org/ -
Recovery of pituitary function in the late-postoperative phase after pituitary surgery : Results of dynamic testing in patients with pituitary disease by insulin tolerance test 3 and 12 months after surgeryIn: European Journal of Endocrinology Jg. 162 (2010) Nr. 5, S. 853 - 859ISSN: 1479-683X; 0804-4643Online Volltext: dx.doi.org/
-
The Effect of Pegvisomant on Cardiovascular Risk in Patients with Active Acromegaly in Comparison to Matched Data from the General Population
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine Reviews Jg. 31 (2010) Nr. 3, Suppl. 1, S. 857, OR16-6ISSN: 0163-769X; 1945-7189Online Volltext: dx.doi.org/ -
The Effect of Pegvisomant on Glucose Metabolism and Insulin Levels in Healthy Adults
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine reviews: issued quarterly for the Endocrine Society Jg. 31 (2010) Nr. Suppl. 1, S. P3 - 250ISSN: 0163-769X; 1945-7189Online Volltext: dx.doi.org/ -
The rational use of pituitary stimulation testsIn: Deutsches Ärzteblatt international Jg. 107 (2010) Nr. 25, S. 437 - 443ISSN: 1866-0452Online Volltext: dx.doi.org/ (Open Access)
-
Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epitheliumIn: Hormone and Metabolic Research Jg. 40 (2008) Nr. 3, S. 210 - 213ISSN: 0018-5043; 1439-4286Online Volltext: dx.doi.org/
-
Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research Jg. 40 (2008) Nr. 3, S. 181 - 188ISSN: 0018-5043; 1439-4286Online Volltext: dx.doi.org/
-
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumoursIn: Clinical Endocrinology Jg. 68 (2008) Nr. 6, S. 850 - 857ISSN: 1365-2265; 0300-0664Online Volltext: dx.doi.org/
-
Retroperitoneoscopic Adrenalectomy in Conn’s Syndrome Caused by Adrenal Adenomas or Nodular HyperplasiaIn: World Journal of Surgery Jg. 32 (2008) Nr. 5, S. 847 - 853ISSN: 1432-2323; 0364-2313Online Volltext: dx.doi.org/
-
Androgenproduzierender Leydig-Zell-Tumor des Ovars als Ursache von Hirsutismus bei einer postmenopausalen FrauIn: Medizinische Klinik Jg. 102 (2007) Nr. 3, S. 259 - 262ISSN: 0723-5003; 1615-6722Online Volltext: dx.doi.org/
-
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal massIn: European Journal of Endocrinology Jg. 154 (2006) Nr. 3, S. 409 - 417ISSN: 0804-4643; 1479-683XOnline Volltext: dx.doi.org/ (Open Access)
-
Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: Results of 161 tumors in 126 patientsIn: World Journal of Surgery Jg. 30 (2006) Nr. 5, S. 899 - 908ISSN: 0364-2313; 1432-2323Online Volltext: dx.doi.org/
-
Posterior retroperitoneoscopic adrenalectomy-results of 560 procedures in 520 patientsIn: Surgery Jg. 140 (2006) Nr. 6, S. 943 - 950ISSN: 1532-7361; 0039-6060Online Volltext: dx.doi.org/
-
Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research Jg. 37 (2005) Nr. 12, S. 722 - 728ISSN: 0018-5043; 1439-4286Online Volltext: dx.doi.org/
-
Endoscopic treatment of large primary adrenal tumoursIn: British Journal of Surgery Jg. 92 (2005) Nr. 6, S. 719 - 723ISSN: 0007-1323; 1365-2168Online Volltext: dx.doi.org/
-
Neuroendokrine Tumoren : Seltene medizinische PhänomeneIn: Essener Unikate: Berichte aus Forschung und Lehre (2005) Nr. 25 : Medizin – Unsere Hormone, S. 62 - 75ISSN: 1869-3881Online Volltext (Open Access)
-
Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4, and 5 in various adrenal tumorsIn: Endocrine Research Jg. 30 (2004) Nr. 4, S. 931 - 934ISSN: 0743-5800; 1532-4206Online Volltext: dx.doi.org/
-
Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach : Early and long-term results of 325 consecutive procedures in primary adrenal neoplasiasIn: World Journal of Surgery Jg. 28 (2004) Nr. 12, S. 1323 - 1329ISSN: 0364-2313; 1432-2323Online Volltext: dx.doi.org/
-
Neurohormone steuern das Leben : Hormone als Vermittler zwischen Zentralnervensystem und peripheren OrganenIn: Essener Unikate: Berichte aus Forschung und Lehre (2003) Nr. 22 : Neurowissenschaften – Wir und unser Gehirn, S. 30 - 41ISSN: 1869-3881Online Volltext (Open Access)
-
Association of Somatostatin Receptor 2 Immunohistochemical Expression with [111In]-DTPA Octreotide Scintigraphy and [68Ga]-DOTATOC PET/CT in Neuroendocrine Tumors
7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease March 11–12, 2010 Berlin, Germany,In: Neuroendocrinology Jg. 92 (2010) Nr. 1, S. 47ISSN: 0028-3835; 1423-0194Online Volltext: dx.doi.org/ -
Chemotherapy in the Treatment of Progressive, Undifferentiated Neuroendocrine Carcinomas : A Single-Center Experience
7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease March 11–12, 2010 Berlin, Germany,In: Neuroendocrinology Jg. 92 (2010) Nr. 1, S. 27ISSN: 0028-3835; 1423-0194Online Volltext: dx.doi.org/ -
Differential Uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of Gastroenteropancreatic Neuroendocrine TumorsIn: Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment / Baum, Richard P.; Rösch, Frank (Hrsg.) 2013, S. 353 - 371ISBN: 978-3-642-27993-5; 978-3-642-27994-2Online Volltext: dx.doi.org/
-
Pituitary tumors : a comprehensive and interdisciplinary approachLondon (2021) 722 SeitenISBN: 978-0-12-819949-7; 978-0-12-819950-3Online Volltext: dx.doi.org/